Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE MKT LLC:BTX)

During the Trading Day
2.19 -0.11 / -4.78%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.21 +0.0191 / +0.87%
 
Volume: 4.6K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$218.3M

Company Description

BioTime, Inc. is a biotechnology company, which is focused on regenerative medicine and blood plasma volume expanders. The company provides research and product development in the field of regenerative medicine. It develops blood plasma volume expanders, blood replacement solutions for hypothermic surgery and technology for use in surgery, emergency trauma treatment and other applications. The company focuses in the field of emerging field of regenerative medicine; specifically human embryonic stem cell and induced pluripotent stem cell technology. BioTime was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Alameda, CA.

Contact Information

BioTime, Inc.
1301 Harbor Bay Parkway
Alameda California 94502
P:(510) 521-3390
Investor Relations:
5105213390367

Employees

Shareholders

Mutual fund holders6.57%
Individual stakeholders39.80%
Other institutional39.79%

Top Executives

Michael D. WestCo-President, Co-CEO & Director
Aditya P. MohantyCo-President & Co-Chief Executive Officer
Russell L. SkibstedChief Financial Officer
Hal SternbergVice President-Research
Judith SegallSecretary, Director & VP-Administration